#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Model-Free Functional Connectivity and Impulsivity Correlates of Alcohol Dependence: A Resting-State Study Background Alcohol dependence is characterized by impulsiveness toward consumption despite negative consequences.
1-1	0-10	Model-Free	_
1-2	11-21	Functional	_
1-3	22-34	Connectivity	_
1-4	35-38	and	_
1-5	39-50	Impulsivity	_
1-6	51-61	Correlates	_
1-7	62-64	of	_
1-8	65-72	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-9	73-83	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-10	84-85	:	_
1-11	86-87	A	_
1-12	88-101	Resting-State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-13	102-107	Study	_
1-14	108-118	Background	_
1-15	119-126	Alcohol	_
1-16	127-137	dependence	_
1-17	138-140	is	_
1-18	141-154	characterized	_
1-19	155-157	by	_
1-20	158-171	impulsiveness	_
1-21	172-178	toward	_
1-22	179-190	consumption	_
1-23	191-198	despite	_
1-24	199-207	negative	_
1-25	208-220	consequences	_
1-26	221-222	.	_

Text=Although neuroimaging studies have implicated some regions underlying this disorder, there is little information regarding its large-scale connectivity pattern.
2-1	223-231	Although	_
2-2	232-244	neuroimaging	_
2-3	245-252	studies	_
2-4	253-257	have	_
2-5	258-268	implicated	_
2-6	269-273	some	_
2-7	274-281	regions	_
2-8	282-292	underlying	_
2-9	293-297	this	_
2-10	298-306	disorder	_
2-11	307-308	,	_
2-12	309-314	there	_
2-13	315-317	is	_
2-14	318-324	little	_
2-15	325-336	information	_
2-16	337-346	regarding	_
2-17	347-350	its	_
2-18	351-362	large-scale	_
2-19	363-375	connectivity	_
2-20	376-383	pattern	_
2-21	384-385	.	_

Text=This study investigated the within- and between-network functional connectivity (FC) in alcohol dependence and examined its relationship with clinical impulsivity measures.
3-1	386-390	This	_
3-2	391-396	study	_
3-3	397-409	investigated	_
3-4	410-413	the	_
3-5	414-421	within-	_
3-6	422-425	and	_
3-7	426-441	between-network	_
3-8	442-452	functional	_
3-9	453-465	connectivity	_
3-10	466-467	(	_
3-11	468-470	FC	_
3-12	471-472	)	_
3-13	473-475	in	_
3-14	476-483	alcohol	_
3-15	484-494	dependence	_
3-16	495-498	and	_
3-17	499-507	examined	_
3-18	508-511	its	_
3-19	512-524	relationship	_
3-20	525-529	with	_
3-21	530-538	clinical	_
3-22	539-550	impulsivity	_
3-23	551-559	measures	_
3-24	560-561	.	_

Text=Methods Using Probabilistic Independent Component Analysis (PICA) on resting-state fMRI (rs-fMRI) data from 25 alcohol dependent (AD) and 26 healthy control (HC) participants, we compared the within- and between-network FC between AD and HC.
4-1	562-569	Methods	_
4-2	570-575	Using	_
4-3	576-589	Probabilistic	_
4-4	590-601	Independent	_
4-5	602-611	Component	_
4-6	612-620	Analysis	_
4-7	621-622	(	_
4-8	623-627	PICA	_
4-9	628-629	)	_
4-10	630-632	on	_
4-11	633-646	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-12	647-651	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-13	652-653	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-14	654-661	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-15	662-663	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
4-16	664-668	data	_
4-17	669-673	from	_
4-18	674-676	25	_
4-19	677-684	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
4-20	685-694	dependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
4-21	695-696	(	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
4-22	697-699	AD	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
4-23	700-701	)	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
4-24	702-705	and	_
4-25	706-708	26	_
4-26	709-716	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-27	717-724	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-28	725-726	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-29	727-729	HC	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-30	730-731	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
4-31	732-744	participants	_
4-32	745-746	,	_
4-33	747-749	we	_
4-34	750-758	compared	_
4-35	759-762	the	_
4-36	763-770	within-	_
4-37	771-774	and	_
4-38	775-790	between-network	_
4-39	791-793	FC	_
4-40	794-801	between	_
4-41	802-804	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
4-42	805-808	and	_
4-43	809-811	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-44	812-813	.	_

Text=Then, the relationship between FC and impulsiveness as measured by the Barratt Impulsiveness Scale (BIS-11), the UPPS-P Impulsive Scale and the delay-discounting task (DDT) was explored.
5-1	814-818	Then	_
5-2	819-820	,	_
5-3	821-824	the	_
5-4	825-837	relationship	_
5-5	838-845	between	_
5-6	846-848	FC	_
5-7	849-852	and	_
5-8	853-866	impulsiveness	_
5-9	867-869	as	_
5-10	870-878	measured	_
5-11	879-881	by	_
5-12	882-885	the	_
5-13	886-893	Barratt	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-14	894-907	Impulsiveness	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-15	908-913	Scale	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-16	914-915	(	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-17	916-922	BIS-11	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-18	923-924	)	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
5-19	925-926	,	_
5-20	927-930	the	_
5-21	931-937	UPPS-P	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale
5-22	938-947	Impulsive	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale
5-23	948-953	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale
5-24	954-957	and	_
5-25	958-961	the	_
5-26	962-979	delay-discounting	http://maven.renci.org/NeuroBridge/neurobridge#FingerTappingTask
5-27	980-984	task	http://maven.renci.org/NeuroBridge/neurobridge#FingerTappingTask
5-28	985-986	(	http://maven.renci.org/NeuroBridge/neurobridge#FingerTappingTask
5-29	987-990	DDT	http://maven.renci.org/NeuroBridge/neurobridge#FingerTappingTask
5-30	991-992	)	http://maven.renci.org/NeuroBridge/neurobridge#FingerTappingTask
5-31	993-996	was	_
5-32	997-1005	explored	_
5-33	1006-1007	.	_

Text=Results Compared to HC, AD exhibited increased within-network FC in salience (SN), default-mode (DMN), orbitofrontal cortex (OFCN), left executive control (LECN) and amygdala-striatum (ASN) networks.
6-1	1008-1015	Results	_
6-2	1016-1024	Compared	_
6-3	1025-1027	to	_
6-4	1028-1030	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
6-5	1031-1032	,	_
6-6	1033-1035	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
6-7	1036-1045	exhibited	_
6-8	1046-1055	increased	_
6-9	1056-1070	within-network	_
6-10	1071-1073	FC	_
6-11	1074-1076	in	_
6-12	1077-1085	salience	_
6-13	1086-1087	(	_
6-14	1088-1090	SN	_
6-15	1091-1092	)	_
6-16	1093-1094	,	_
6-17	1095-1107	default-mode	_
6-18	1108-1109	(	_
6-19	1110-1113	DMN	_
6-20	1114-1115	)	_
6-21	1116-1117	,	_
6-22	1118-1131	orbitofrontal	_
6-23	1132-1138	cortex	_
6-24	1139-1140	(	_
6-25	1141-1145	OFCN	_
6-26	1146-1147	)	_
6-27	1148-1149	,	_
6-28	1150-1154	left	_
6-29	1155-1164	executive	_
6-30	1165-1172	control	_
6-31	1173-1174	(	_
6-32	1175-1179	LECN	_
6-33	1180-1181	)	_
6-34	1182-1185	and	_
6-35	1186-1203	amygdala-striatum	_
6-36	1204-1205	(	_
6-37	1206-1209	ASN	_
6-38	1210-1211	)	_
6-39	1212-1220	networks	_
6-40	1221-1222	.	_

Text=Increased between-network FC was found among LECN, ASN and SN.
7-1	1223-1232	Increased	_
7-2	1233-1248	between-network	_
7-3	1249-1251	FC	_
7-4	1252-1255	was	_
7-5	1256-1261	found	_
7-6	1262-1267	among	_
7-7	1268-1272	LECN	_
7-8	1273-1274	,	_
7-9	1275-1278	ASN	http://maven.renci.org/NeuroBridge/neurobridge#Thing
7-10	1279-1282	and	_
7-11	1283-1285	SN	_
7-12	1286-1287	.	_

Text=Between-network FC correlations were significantly negative between Negative-Urgency and OFCN pairs with RECN, anterior DMN (aDMN), and posterior DMN (pDMN) in AD.
8-1	1288-1303	Between-network	_
8-2	1304-1306	FC	_
8-3	1307-1319	correlations	_
8-4	1320-1324	were	_
8-5	1325-1338	significantly	_
8-6	1339-1347	negative	_
8-7	1348-1355	between	_
8-8	1356-1372	Negative-Urgency	_
8-9	1373-1376	and	_
8-10	1377-1381	OFCN	_
8-11	1382-1387	pairs	_
8-12	1388-1392	with	_
8-13	1393-1397	RECN	_
8-14	1398-1399	,	_
8-15	1400-1408	anterior	_
8-16	1409-1412	DMN	_
8-17	1413-1414	(	_
8-18	1415-1419	aDMN	_
8-19	1420-1421	)	_
8-20	1422-1423	,	_
8-21	1424-1427	and	_
8-22	1428-1437	posterior	_
8-23	1438-1441	DMN	_
8-24	1442-1443	(	_
8-25	1444-1448	pDMN	_
8-26	1449-1450	)	_
8-27	1451-1453	in	_
8-28	1454-1456	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
8-29	1457-1458	.	_

Text=DDT was significantly correlated with the between-network FC among the LECN, aDMN and SN in AD.
9-1	1459-1462	DDT	_
9-2	1463-1466	was	_
9-3	1467-1480	significantly	_
9-4	1481-1491	correlated	_
9-5	1492-1496	with	_
9-6	1497-1500	the	_
9-7	1501-1516	between-network	_
9-8	1517-1519	FC	_
9-9	1520-1525	among	_
9-10	1526-1529	the	_
9-11	1530-1534	LECN	_
9-12	1535-1536	,	_
9-13	1537-1541	aDMN	_
9-14	1542-1545	and	_
9-15	1546-1548	SN	_
9-16	1549-1551	in	_
9-17	1552-1554	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
9-18	1555-1556	.	_

Text=Conclusions These findings add evidence to the concept of altered within-network FC and also highlight the role of between-network FC in the pathophysiology of AD.
10-1	1557-1568	Conclusions	_
10-2	1569-1574	These	_
10-3	1575-1583	findings	_
10-4	1584-1587	add	_
10-5	1588-1596	evidence	_
10-6	1597-1599	to	_
10-7	1600-1603	the	_
10-8	1604-1611	concept	_
10-9	1612-1614	of	_
10-10	1615-1622	altered	_
10-11	1623-1637	within-network	_
10-12	1638-1640	FC	_
10-13	1641-1644	and	_
10-14	1645-1649	also	_
10-15	1650-1659	highlight	_
10-16	1660-1663	the	_
10-17	1664-1668	role	_
10-18	1669-1671	of	_
10-19	1672-1687	between-network	_
10-20	1688-1690	FC	_
10-21	1691-1693	in	_
10-22	1694-1697	the	_
10-23	1698-1713	pathophysiology	_
10-24	1714-1716	of	_
10-25	1717-1719	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
10-26	1720-1721	.	_

Text=Additionally, this study suggests differential neurobiological bases for different clinical measures of impulsivity that may be used as a systems-level biomarker for alcohol dependence severity and treatment efficacy.
11-1	1722-1734	Additionally	_
11-2	1735-1736	,	_
11-3	1737-1741	this	_
11-4	1742-1747	study	_
11-5	1748-1756	suggests	_
11-6	1757-1769	differential	_
11-7	1770-1785	neurobiological	_
11-8	1786-1791	bases	_
11-9	1792-1795	for	_
11-10	1796-1805	different	_
11-11	1806-1814	clinical	_
11-12	1815-1823	measures	_
11-13	1824-1826	of	_
11-14	1827-1838	impulsivity	_
11-15	1839-1843	that	_
11-16	1844-1847	may	_
11-17	1848-1850	be	_
11-18	1851-1855	used	_
11-19	1856-1858	as	_
11-20	1859-1860	a	_
11-21	1861-1874	systems-level	_
11-22	1875-1884	biomarker	_
11-23	1885-1888	for	_
11-24	1889-1896	alcohol	_
11-25	1897-1907	dependence	_
11-26	1908-1916	severity	_
11-27	1917-1920	and	_
11-28	1921-1930	treatment	_
11-29	1931-1939	efficacy	_
11-30	1940-1941	.	_

Text=Methods and Materials 2.1 Participants Twenty-five alcohol-dependent (AD) subjects (8 females) with an average age of 31.9 years (range: 21 to 44, std: 7.7) and 26 healthy controls (HC) subjects (15 females) with mean age at examination of 26.3 years (range: 22 to 37, std: 3.9) were examined (Table 1).
12-1	1942-1949	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	1950-1953	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	1954-1963	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	1964-1967	2.1	_
12-5	1968-1980	Participants	_
12-6	1981-1992	Twenty-five	_
12-7	1993-2010	alcohol-dependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
12-8	2011-2012	(	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
12-9	2013-2015	AD	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
12-10	2016-2017	)	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
12-11	2018-2026	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse
12-12	2027-2028	(	_
12-13	2029-2030	8	_
12-14	2031-2038	females	_
12-15	2039-2040	)	_
12-16	2041-2045	with	_
12-17	2046-2048	an	_
12-18	2049-2056	average	_
12-19	2057-2060	age	_
12-20	2061-2063	of	_
12-21	2064-2068	31.9	_
12-22	2069-2074	years	_
12-23	2075-2076	(	_
12-24	2077-2082	range	_
12-25	2083-2084	:	_
12-26	2085-2087	21	_
12-27	2088-2090	to	_
12-28	2091-2093	44	_
12-29	2094-2095	,	_
12-30	2096-2099	std	_
12-31	2100-2101	:	_
12-32	2102-2105	7.7	_
12-33	2106-2107	)	_
12-34	2108-2111	and	_
12-35	2112-2114	26	_
12-36	2115-2122	healthy	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-37	2123-2131	controls	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-38	2132-2133	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-39	2134-2136	HC	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-40	2137-2138	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-41	2139-2147	subjects	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
12-42	2148-2149	(	_
12-43	2150-2152	15	_
12-44	2153-2160	females	_
12-45	2161-2162	)	_
12-46	2163-2167	with	_
12-47	2168-2172	mean	_
12-48	2173-2176	age	_
12-49	2177-2179	at	_
12-50	2180-2191	examination	_
12-51	2192-2194	of	_
12-52	2195-2199	26.3	_
12-53	2200-2205	years	_
12-54	2206-2207	(	_
12-55	2208-2213	range	_
12-56	2214-2215	:	_
12-57	2216-2218	22	_
12-58	2219-2221	to	_
12-59	2222-2224	37	_
12-60	2225-2226	,	_
12-61	2227-2230	std	_
12-62	2231-2232	:	_
12-63	2233-2236	3.9	_
12-64	2237-2238	)	_
12-65	2239-2243	were	_
12-66	2244-2252	examined	_
12-67	2253-2254	(	_
12-68	2255-2260	Table	_
12-69	2261-2262	1	_
12-70	2263-2264	)	_
12-71	2265-2266	.	_

Text=Healthy controls were recruited through newspaper advertisements and information notices distributed in the Washington, D.C. metropolitan area.
13-1	2267-2274	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-2	2275-2283	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-3	2284-2288	were	_
13-4	2289-2298	recruited	_
13-5	2299-2306	through	_
13-6	2307-2316	newspaper	_
13-7	2317-2331	advertisements	_
13-8	2332-2335	and	_
13-9	2336-2347	information	_
13-10	2348-2355	notices	_
13-11	2356-2367	distributed	_
13-12	2368-2370	in	_
13-13	2371-2374	the	_
13-14	2375-2385	Washington	_
13-15	2386-2387	,	_
13-16	2388-2392	D.C.	_
13-17	2393-2405	metropolitan	_
13-18	2406-2410	area	_
13-19	2411-2412	.	_

Text=Subjects comprising the alcohol-dependent group were recruited from the inpatient alcohol treatment unit at the National Institutes of Health Clinical Research Center in Bethesda, Maryland.
14-1	2413-2421	Subjects	_
14-2	2422-2432	comprising	_
14-3	2433-2436	the	_
14-4	2437-2454	alcohol-dependent	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
14-5	2455-2460	group	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
14-6	2461-2465	were	_
14-7	2466-2475	recruited	_
14-8	2476-2480	from	_
14-9	2481-2484	the	_
14-10	2485-2494	inpatient	_
14-11	2495-2502	alcohol	_
14-12	2503-2512	treatment	_
14-13	2513-2517	unit	_
14-14	2518-2520	at	_
14-15	2521-2524	the	_
14-16	2525-2533	National	_
14-17	2534-2544	Institutes	_
14-18	2545-2547	of	_
14-19	2548-2554	Health	_
14-20	2555-2563	Clinical	_
14-21	2564-2572	Research	_
14-22	2573-2579	Center	_
14-23	2580-2582	in	_
14-24	2583-2591	Bethesda	_
14-25	2592-2593	,	_
14-26	2594-2602	Maryland	_
14-27	2603-2604	.	_

Text=Written informed consent to the study was obtained from all of subjects, which was approved by the Institutional Review Board of the National Institute on Alcohol Abuse and Alcoholism.
15-1	2605-2612	Written	_
15-2	2613-2621	informed	_
15-3	2622-2629	consent	_
15-4	2630-2632	to	_
15-5	2633-2636	the	_
15-6	2637-2642	study	_
15-7	2643-2646	was	_
15-8	2647-2655	obtained	_
15-9	2656-2660	from	_
15-10	2661-2664	all	_
15-11	2665-2667	of	_
15-12	2668-2676	subjects	_
15-13	2677-2678	,	_
15-14	2679-2684	which	_
15-15	2685-2688	was	_
15-16	2689-2697	approved	_
15-17	2698-2700	by	_
15-18	2701-2704	the	_
15-19	2705-2718	Institutional	_
15-20	2719-2725	Review	_
15-21	2726-2731	Board	_
15-22	2732-2734	of	_
15-23	2735-2738	the	_
15-24	2739-2747	National	_
15-25	2748-2757	Institute	_
15-26	2758-2760	on	_
15-27	2761-2768	Alcohol	_
15-28	2769-2774	Abuse	_
15-29	2775-2778	and	_
15-30	2779-2789	Alcoholism	_
15-31	2790-2791	.	_

Text=2.2 Assessments The Structured Clinical Interview for DSM-IV-TR (SCID) was administered to all participants to determine diagnoses of alcohol dependence as well as other substance use and psychiatric disorders.
16-1	2792-2795	2.2	_
16-2	2796-2807	Assessments	_
16-3	2808-2811	The	_
16-4	2812-2822	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-5	2823-2831	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-6	2832-2841	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-7	2842-2845	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-8	2846-2855	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-9	2856-2857	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-10	2858-2862	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-11	2863-2864	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-12	2865-2868	was	_
16-13	2869-2881	administered	_
16-14	2882-2884	to	_
16-15	2885-2888	all	_
16-16	2889-2901	participants	_
16-17	2902-2904	to	_
16-18	2905-2914	determine	_
16-19	2915-2924	diagnoses	_
16-20	2925-2927	of	_
16-21	2928-2935	alcohol	_
16-22	2936-2946	dependence	_
16-23	2947-2949	as	_
16-24	2950-2954	well	_
16-25	2955-2957	as	_
16-26	2958-2963	other	_
16-27	2964-2973	substance	_
16-28	2974-2977	use	_
16-29	2978-2981	and	_
16-30	2982-2993	psychiatric	_
16-31	2994-3003	disorders	_
16-32	3004-3005	.	_

Text=The Wechsler Adult Intelligence Scale (WAIS-III) was administered to determine the intelligence quotient (IQ) of all participants.
17-1	3006-3009	The	_
17-2	3010-3018	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-3	3019-3024	Adult	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-4	3025-3037	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-5	3038-3043	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-6	3044-3045	(	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-7	3046-3054	WAIS-III	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-8	3055-3056	)	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
17-9	3057-3060	was	_
17-10	3061-3073	administered	_
17-11	3074-3076	to	_
17-12	3077-3086	determine	_
17-13	3087-3090	the	_
17-14	3091-3103	intelligence	_
17-15	3104-3112	quotient	_
17-16	3113-3114	(	_
17-17	3115-3117	IQ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
17-18	3118-3119	)	_
17-19	3120-3122	of	_
17-20	3123-3126	all	_
17-21	3127-3139	participants	_
17-22	3140-3141	.	_

Text=A 90 day Timeline Followback (TLFB) calendar was used to measure the frequency and amount of drinking for all subjects.
18-1	3142-3143	A	_
18-2	3144-3146	90	_
18-3	3147-3150	day	_
18-4	3151-3159	Timeline	_
18-5	3160-3170	Followback	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
18-6	3171-3172	(	_
18-7	3173-3177	TLFB	_
18-8	3178-3179	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
18-9	3180-3188	calendar	_
18-10	3189-3192	was	_
18-11	3193-3197	used	_
18-12	3198-3200	to	_
18-13	3201-3208	measure	_
18-14	3209-3212	the	_
18-15	3213-3222	frequency	_
18-16	3223-3226	and	_
18-17	3227-3233	amount	_
18-18	3234-3236	of	_
18-19	3237-3245	drinking	_
18-20	3246-3249	for	_
18-21	3250-3253	all	_
18-22	3254-3262	subjects	_
18-23	3263-3264	.	_

Text=The first dimension of impulsivity, trait-impulsivity, was measured by the Barratt Impulsiveness Scale (BIS-11), which is one of the most widely-used self-report measures of trait-impulsivity, refers to aspects of inattention, spontaneous actions, and lack of forethought.
19-1	3265-3268	The	_
19-2	3269-3274	first	_
19-3	3275-3284	dimension	_
19-4	3285-3287	of	_
19-5	3288-3299	impulsivity	_
19-6	3300-3301	,	_
19-7	3302-3319	trait-impulsivity	_
19-8	3320-3321	,	_
19-9	3322-3325	was	_
19-10	3326-3334	measured	_
19-11	3335-3337	by	_
19-12	3338-3341	the	_
19-13	3342-3349	Barratt	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
19-14	3350-3363	Impulsiveness	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
19-15	3364-3369	Scale	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
19-16	3370-3371	(	http://maven.renci.org/NeuroBridge/neurobridge#BarrattImpulsivenessQuestionnaire
19-17	3372-3378	BIS-11	_
19-18	3379-3380	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
19-19	3381-3382	,	_
19-20	3383-3388	which	_
19-21	3389-3391	is	_
19-22	3392-3395	one	_
19-23	3396-3398	of	_
19-24	3399-3402	the	_
19-25	3403-3407	most	_
19-26	3408-3419	widely-used	_
19-27	3420-3431	self-report	_
19-28	3432-3440	measures	_
19-29	3441-3443	of	_
19-30	3444-3461	trait-impulsivity	_
19-31	3462-3463	,	_
19-32	3464-3470	refers	_
19-33	3471-3473	to	_
19-34	3474-3481	aspects	_
19-35	3482-3484	of	_
19-36	3485-3496	inattention	_
19-37	3497-3498	,	_
19-38	3499-3510	spontaneous	_
19-39	3511-3518	actions	_
19-40	3519-3520	,	_
19-41	3521-3524	and	_
19-42	3525-3529	lack	_
19-43	3530-3532	of	_
19-44	3533-3544	forethought	_
19-45	3545-3546	.	_

Text=Another one is the UPPS-P Impulsive Behavior Scale (UPPS).
20-1	3547-3554	Another	_
20-2	3555-3558	one	_
20-3	3559-3561	is	_
20-4	3562-3565	the	_
20-5	3566-3572	UPPS-P	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-6	3573-3582	Impulsive	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-7	3583-3591	Behavior	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-8	3592-3597	Scale	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-9	3598-3599	(	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-10	3600-3604	UPPS	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-11	3605-3606	)	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
20-12	3607-3608	.	_

Text=This scale measures impulsivity across the Five-Factor Model of personality, measuring in this way distinct personality traits that lead to impulsive behavior.
21-1	3609-3613	This	_
21-2	3614-3619	scale	_
21-3	3620-3628	measures	_
21-4	3629-3640	impulsivity	_
21-5	3641-3647	across	_
21-6	3648-3651	the	_
21-7	3652-3663	Five-Factor	_
21-8	3664-3669	Model	_
21-9	3670-3672	of	_
21-10	3673-3684	personality	_
21-11	3685-3686	,	_
21-12	3687-3696	measuring	_
21-13	3697-3699	in	_
21-14	3700-3704	this	_
21-15	3705-3708	way	_
21-16	3709-3717	distinct	_
21-17	3718-3729	personality	_
21-18	3730-3736	traits	_
21-19	3737-3741	that	_
21-20	3742-3746	lead	_
21-21	3747-3749	to	_
21-22	3750-3759	impulsive	_
21-23	3760-3768	behavior	_
21-24	3769-3770	.	_

Text=It includes Urgency (negative) (UPPS (−)), Premeditation (lack of), Perseverance (lack of), Sensation-seeking, and Positive-urgency (UPPS (+)).
22-1	3771-3773	It	_
22-2	3774-3782	includes	_
22-3	3783-3790	Urgency	_
22-4	3791-3792	(	_
22-5	3793-3801	negative	_
22-6	3802-3803	)	_
22-7	3804-3805	(	_
22-8	3806-3810	UPPS	_
22-9	3811-3812	(	_
22-10	3813-3814	−	_
22-11	3815-3816	)	_
22-12	3817-3818	)	_
22-13	3819-3820	,	_
22-14	3821-3834	Premeditation	_
22-15	3835-3836	(	_
22-16	3837-3841	lack	_
22-17	3842-3844	of	_
22-18	3845-3846	)	_
22-19	3847-3848	,	_
22-20	3849-3861	Perseverance	_
22-21	3862-3863	(	_
22-22	3864-3868	lack	_
22-23	3869-3871	of	_
22-24	3872-3873	)	_
22-25	3874-3875	,	_
22-26	3876-3893	Sensation-seeking	_
22-27	3894-3895	,	_
22-28	3896-3899	and	_
22-29	3900-3916	Positive-urgency	_
22-30	3917-3918	(	_
22-31	3919-3923	UPPS	_
22-32	3924-3925	(	_
22-33	3926-3927	+	_
22-34	3928-3929	)	_
22-35	3930-3931	)	_
22-36	3932-3933	.	_

Text=Second dimension of impulsivity is choice impulsivity.
23-1	3934-3940	Second	_
23-2	3941-3950	dimension	_
23-3	3951-3953	of	_
23-4	3954-3965	impulsivity	_
23-5	3966-3968	is	_
23-6	3969-3975	choice	_
23-7	3976-3987	impulsivity	_
23-8	3988-3989	.	_

Text=This deficiency was measured by delay discounting task (DDT).
24-1	3990-3994	This	_
24-2	3995-4005	deficiency	_
24-3	4006-4009	was	_
24-4	4010-4018	measured	_
24-5	4019-4021	by	_
24-6	4022-4027	delay	_
24-7	4028-4039	discounting	_
24-8	4040-4044	task	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
24-9	4045-4046	(	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
24-10	4047-4050	DDT	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
24-11	4051-4052	)	http://maven.renci.org/NeuroBridge/neurobridge#GoNoGoTask
24-12	4053-4054	.	_

Text=The DDT measures impulsivity by presenting the subject with an option between receiving a smaller immediate monetary reward or a potentially greater delayed reward.
25-1	4055-4058	The	_
25-2	4059-4062	DDT	_
25-3	4063-4071	measures	_
25-4	4072-4083	impulsivity	_
25-5	4084-4086	by	_
25-6	4087-4097	presenting	_
25-7	4098-4101	the	_
25-8	4102-4109	subject	_
25-9	4110-4114	with	_
25-10	4115-4117	an	_
25-11	4118-4124	option	_
25-12	4125-4132	between	_
25-13	4133-4142	receiving	_
25-14	4143-4144	a	_
25-15	4145-4152	smaller	_
25-16	4153-4162	immediate	_
25-17	4163-4171	monetary	_
25-18	4172-4178	reward	_
25-19	4179-4181	or	_
25-20	4182-4183	a	_
25-21	4184-4195	potentially	_
25-22	4196-4203	greater	_
25-23	4204-4211	delayed	_
25-24	4212-4218	reward	_
25-25	4219-4220	.	_

Text=Participants were presented with a choice between an immediate reward and a fixed larger ($100) but delayed (zero to 30 days) rewards.
26-1	4221-4233	Participants	_
26-2	4234-4238	were	_
26-3	4239-4248	presented	_
26-4	4249-4253	with	_
26-5	4254-4255	a	_
26-6	4256-4262	choice	_
26-7	4263-4270	between	_
26-8	4271-4273	an	_
26-9	4274-4283	immediate	_
26-10	4284-4290	reward	_
26-11	4291-4294	and	_
26-12	4295-4296	a	_
26-13	4297-4302	fixed	_
26-14	4303-4309	larger	_
26-15	4310-4311	(	_
26-16	4312-4313	$	_
26-17	4314-4317	100	_
26-18	4318-4319	)	_
26-19	4320-4323	but	_
26-20	4324-4331	delayed	_
26-21	4332-4333	(	_
26-22	4334-4338	zero	_
26-23	4339-4341	to	_
26-24	4342-4344	30	_
26-25	4345-4349	days	_
26-26	4350-4351	)	_
26-27	4352-4359	rewards	_
26-28	4360-4361	.	_

Text=Accordingly, a discounting factor k represents the rate of discounting of the delayed outcome.
27-1	4362-4373	Accordingly	_
27-2	4374-4375	,	_
27-3	4376-4377	a	_
27-4	4378-4389	discounting	_
27-5	4390-4396	factor	_
27-6	4397-4398	k	_
27-7	4399-4409	represents	_
27-8	4410-4413	the	_
27-9	4414-4418	rate	_
27-10	4419-4421	of	_
27-11	4422-4433	discounting	_
27-12	4434-4436	of	_
27-13	4437-4440	the	_
27-14	4441-4448	delayed	_
27-15	4449-4456	outcome	_
27-16	4457-4458	.	_

Text=As k values are not normally distributed, a natural log-transformation is usually applied and the ln (k) is used for the analyses.
28-1	4459-4461	As	_
28-2	4462-4463	k	_
28-3	4464-4470	values	_
28-4	4471-4474	are	_
28-5	4475-4478	not	_
28-6	4479-4487	normally	_
28-7	4488-4499	distributed	_
28-8	4500-4501	,	_
28-9	4502-4503	a	_
28-10	4504-4511	natural	_
28-11	4512-4530	log-transformation	_
28-12	4531-4533	is	_
28-13	4534-4541	usually	_
28-14	4542-4549	applied	_
28-15	4550-4553	and	_
28-16	4554-4557	the	_
28-17	4558-4560	ln	_
28-18	4561-4562	(	_
28-19	4563-4564	k	_
28-20	4565-4566	)	_
28-21	4567-4569	is	_
28-22	4570-4574	used	_
28-23	4575-4578	for	_
28-24	4579-4582	the	_
28-25	4583-4591	analyses	_
28-26	4592-4593	.	_

Text=Higher ln (k) values mean greater preference for immediate rewards.
29-1	4594-4600	Higher	_
29-2	4601-4603	ln	_
29-3	4604-4605	(	_
29-4	4606-4607	k	_
29-5	4608-4609	)	_
29-6	4610-4616	values	_
29-7	4617-4621	mean	_
29-8	4622-4629	greater	_
29-9	4630-4640	preference	_
29-10	4641-4644	for	_
29-11	4645-4654	immediate	_
29-12	4655-4662	rewards	_
29-13	4663-4664	.	_

Text=A smoking questionnaire helped to determine the amount and frequency of a participant ’ s cigarette use.
30-1	4665-4666	A	_
30-2	4667-4674	smoking	_
30-3	4675-4688	questionnaire	_
30-4	4689-4695	helped	_
30-5	4696-4698	to	_
30-6	4699-4708	determine	_
30-7	4709-4712	the	_
30-8	4713-4719	amount	_
30-9	4720-4723	and	_
30-10	4724-4733	frequency	_
30-11	4734-4736	of	_
30-12	4737-4738	a	_
30-13	4739-4750	participant	_
30-14	4751-4752	’	_
30-15	4753-4754	s	_
30-16	4755-4764	cigarette	_
30-17	4765-4768	use	_
30-18	4769-4770	.	_

Text=2.3 Exclusionary criteria Exclusionary criteria included pregnancy, claustrophobia, significant neurological, or medical diagnoses.
31-1	4771-4774	2.3	_
31-2	4775-4787	Exclusionary	_
31-3	4788-4796	criteria	_
31-4	4797-4809	Exclusionary	_
31-5	4810-4818	criteria	_
31-6	4819-4827	included	_
31-7	4828-4837	pregnancy	_
31-8	4838-4839	,	_
31-9	4840-4854	claustrophobia	_
31-10	4855-4856	,	_
31-11	4857-4868	significant	_
31-12	4869-4881	neurological	_
31-13	4882-4883	,	_
31-14	4884-4886	or	_
31-15	4887-4894	medical	_
31-16	4895-4904	diagnoses	_
31-17	4905-4906	.	_

Text=Participants were instructed not to consume any alcohol for 24 hours and no more than half a cup of caffeinated beverages 12 hours prior to each scanning visit.
32-1	4907-4919	Participants	_
32-2	4920-4924	were	_
32-3	4925-4935	instructed	_
32-4	4936-4939	not	_
32-5	4940-4942	to	_
32-6	4943-4950	consume	_
32-7	4951-4954	any	_
32-8	4955-4962	alcohol	_
32-9	4963-4966	for	_
32-10	4967-4969	24	_
32-11	4970-4975	hours	_
32-12	4976-4979	and	_
32-13	4980-4982	no	_
32-14	4983-4987	more	_
32-15	4988-4992	than	_
32-16	4993-4997	half	_
32-17	4998-4999	a	_
32-18	5000-5003	cup	_
32-19	5004-5006	of	_
32-20	5007-5018	caffeinated	_
32-21	5019-5028	beverages	_
32-22	5029-5031	12	_
32-23	5032-5037	hours	_
32-24	5038-5043	prior	_
32-25	5044-5046	to	_
32-26	5047-5051	each	_
32-27	5052-5060	scanning	_
32-28	5061-5066	visit	_
32-29	5067-5068	.	_

Text=Participants could not participate if they had a positive alcohol breathalyzer or urine drug screen on the day of the scan.
33-1	5069-5081	Participants	_
33-2	5082-5087	could	_
33-3	5088-5091	not	_
33-4	5092-5103	participate	_
33-5	5104-5106	if	_
33-6	5107-5111	they	_
33-7	5112-5115	had	_
33-8	5116-5117	a	_
33-9	5118-5126	positive	_
33-10	5127-5134	alcohol	_
33-11	5135-5147	breathalyzer	_
33-12	5148-5150	or	_
33-13	5151-5156	urine	_
33-14	5157-5161	drug	_
33-15	5162-5168	screen	_
33-16	5169-5171	on	_
33-17	5172-5175	the	_
33-18	5176-5179	day	_
33-19	5180-5182	of	_
33-20	5183-5186	the	_
33-21	5187-5191	scan	_
33-22	5192-5193	.	_

Text=HC were excluded if they met criteria for any current or past alcohol use disorder.
34-1	5194-5196	HC	_
34-2	5197-5201	were	_
34-3	5202-5210	excluded	_
34-4	5211-5213	if	_
34-5	5214-5218	they	_
34-6	5219-5222	met	_
34-7	5223-5231	criteria	_
34-8	5232-5235	for	_
34-9	5236-5239	any	_
34-10	5240-5247	current	_
34-11	5248-5250	or	_
34-12	5251-5255	past	_
34-13	5256-5263	alcohol	_
34-14	5264-5267	use	_
34-15	5268-5276	disorder	_
34-16	5277-5278	.	_

Text=All subjects were required to be right handed and deemed physically healthy by a clinician.
35-1	5279-5282	All	_
35-2	5283-5291	subjects	_
35-3	5292-5296	were	_
35-4	5297-5305	required	_
35-5	5306-5308	to	_
35-6	5309-5311	be	_
35-7	5312-5317	right	_
35-8	5318-5324	handed	_
35-9	5325-5328	and	_
35-10	5329-5335	deemed	_
35-11	5336-5346	physically	_
35-12	5347-5354	healthy	_
35-13	5355-5357	by	_
35-14	5358-5359	a	_
35-15	5360-5369	clinician	_
35-16	5370-5371	.	_

Text=Subjects were excluded if they had a positive HIV test, active suicidal or homicidal ideations, or were currently taking psychotropic medication.
36-1	5372-5380	Subjects	_
36-2	5381-5385	were	_
36-3	5386-5394	excluded	_
36-4	5395-5397	if	_
36-5	5398-5402	they	_
36-6	5403-5406	had	_
36-7	5407-5408	a	_
36-8	5409-5417	positive	_
36-9	5418-5421	HIV	_
36-10	5422-5426	test	_
36-11	5427-5428	,	_
36-12	5429-5435	active	_
36-13	5436-5444	suicidal	_
36-14	5445-5447	or	_
36-15	5448-5457	homicidal	_
36-16	5458-5467	ideations	_
36-17	5468-5469	,	_
36-18	5470-5472	or	_
36-19	5473-5477	were	_
36-20	5478-5487	currently	_
36-21	5488-5494	taking	_
36-22	5495-5507	psychotropic	_
36-23	5508-5518	medication	_
36-24	5519-5520	.	_

Text=Since the subjects were primarily recruited for fMRI tasks a failed neuromotor examination, which evaluated motor strength, deep tendon reflexes, extraocular movements, gait, and a cerebellar assessment, was also exclusionary.
37-1	5521-5526	Since	_
37-2	5527-5530	the	_
37-3	5531-5539	subjects	_
37-4	5540-5544	were	_
37-5	5545-5554	primarily	_
37-6	5555-5564	recruited	_
37-7	5565-5568	for	_
37-8	5569-5573	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-9	5574-5579	tasks	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
37-10	5580-5581	a	_
37-11	5582-5588	failed	_
37-12	5589-5599	neuromotor	_
37-13	5600-5611	examination	_
37-14	5612-5613	,	_
37-15	5614-5619	which	_
37-16	5620-5629	evaluated	_
37-17	5630-5635	motor	_
37-18	5636-5644	strength	_
37-19	5645-5646	,	_
37-20	5647-5651	deep	_
37-21	5652-5658	tendon	_
37-22	5659-5667	reflexes	_
37-23	5668-5669	,	_
37-24	5670-5681	extraocular	_
37-25	5682-5691	movements	_
37-26	5692-5693	,	_
37-27	5694-5698	gait	_
37-28	5699-5700	,	_
37-29	5701-5704	and	_
37-30	5705-5706	a	_
37-31	5707-5717	cerebellar	_
37-32	5718-5728	assessment	_
37-33	5729-5730	,	_
37-34	5731-5734	was	_
37-35	5735-5739	also	_
37-36	5740-5752	exclusionary	_
37-37	5753-5754	.	_

Text=This allowed the researchers to exclude subjects who may possess neurological deficiencies that could potentially compromise task driven fMRI data.
38-1	5755-5759	This	_
38-2	5760-5767	allowed	_
38-3	5768-5771	the	_
38-4	5772-5783	researchers	_
38-5	5784-5786	to	_
38-6	5787-5794	exclude	_
38-7	5795-5803	subjects	_
38-8	5804-5807	who	_
38-9	5808-5811	may	_
38-10	5812-5819	possess	_
38-11	5820-5832	neurological	_
38-12	5833-5845	deficiencies	_
38-13	5846-5850	that	_
38-14	5851-5856	could	_
38-15	5857-5868	potentially	_
38-16	5869-5879	compromise	_
38-17	5880-5884	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
38-18	5885-5891	driven	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
38-19	5892-5896	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
38-20	5897-5901	data	_
38-21	5902-5903	.	_

Text=AD participants could not have severe symptoms of alcohol withdrawal as determined by a Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) score of greater than 8.
39-1	5904-5906	AD	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence
39-2	5907-5919	participants	http://maven.renci.org/NeuroBridge/neurobridge#MethamphetamineDependence
39-3	5920-5925	could	_
39-4	5926-5929	not	_
39-5	5930-5934	have	_
39-6	5935-5941	severe	_
39-7	5942-5950	symptoms	_
39-8	5951-5953	of	_
39-9	5954-5961	alcohol	_
39-10	5962-5972	withdrawal	_
39-11	5973-5975	as	_
39-12	5976-5986	determined	_
39-13	5987-5989	by	_
39-14	5990-5991	a	_
39-15	5992-6000	Clinical	_
39-16	6001-6010	Institute	_
39-17	6011-6021	Withdrawal	_
39-18	6022-6032	Assessment	_
39-19	6033-6035	of	_
39-20	6036-6043	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
39-21	6044-6049	Scale	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
39-22	6050-6051	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
39-23	6052-6056	CIWA	_
39-24	6057-6058	)	_
39-25	6059-6064	score	_
39-26	6065-6067	of	_
39-27	6068-6075	greater	_
39-28	6076-6080	than	_
39-29	6081-6082	8	_
39-30	6083-6084	.	_

Text=2.4 MRI Data acquisition Whole brain Anatomical images and five minutes of closed-eyes rs-fMRI were collected at the beginning of the scan session using a 3T General Electric MRI scanner (General Electric, Milwaukee, WI) after a short 3D brain localization.
40-1	6085-6088	2.4	_
40-2	6089-6092	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
40-3	6093-6097	Data	_
40-4	6098-6109	acquisition	_
40-5	6110-6115	Whole	_
40-6	6116-6121	brain	_
40-7	6122-6132	Anatomical	_
40-8	6133-6139	images	_
40-9	6140-6143	and	_
40-10	6144-6148	five	_
40-11	6149-6156	minutes	_
40-12	6157-6159	of	_
40-13	6160-6171	closed-eyes	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-14	6172-6179	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-15	6180-6184	were	_
40-16	6185-6194	collected	_
40-17	6195-6197	at	_
40-18	6198-6201	the	_
40-19	6202-6211	beginning	_
40-20	6212-6214	of	_
40-21	6215-6218	the	_
40-22	6219-6223	scan	_
40-23	6224-6231	session	_
40-24	6232-6237	using	_
40-25	6238-6239	a	_
40-26	6240-6242	3T	_
40-27	6243-6250	General	_
40-28	6251-6259	Electric	_
40-29	6260-6263	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
40-30	6264-6271	scanner	_
40-31	6272-6273	(	_
40-32	6274-6281	General	_
40-33	6282-6290	Electric	_
40-34	6291-6292	,	_
40-35	6293-6302	Milwaukee	_
40-36	6303-6304	,	_
40-37	6305-6307	WI	_
40-38	6308-6309	)	_
40-39	6310-6315	after	_
40-40	6316-6317	a	_
40-41	6318-6323	short	_
40-42	6324-6326	3D	_
40-43	6327-6332	brain	_
40-44	6333-6345	localization	_
40-45	6346-6347	.	_

Text=High-resolution T1-weighted 3-D structural scans were acquired for each subject using an MPRAGE sequence (128 axial slices, TR = 1200ms TE =30ms, 256 × 256 matrix).
41-1	6348-6363	High-resolution	_
41-2	6364-6375	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
41-3	6376-6379	3-D	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
41-4	6380-6390	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
41-5	6391-6396	scans	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
41-6	6397-6401	were	_
41-7	6402-6410	acquired	_
41-8	6411-6414	for	_
41-9	6415-6419	each	_
41-10	6420-6427	subject	_
41-11	6428-6433	using	_
41-12	6434-6436	an	_
41-13	6437-6443	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
41-14	6444-6452	sequence	_
41-15	6453-6454	(	_
41-16	6455-6458	128	_
41-17	6459-6464	axial	_
41-18	6465-6471	slices	_
41-19	6472-6473	,	_
41-20	6474-6476	TR	_
41-21	6477-6478	=	_
41-22	6479-6485	1200ms	_
41-23	6486-6488	TE	_
41-24	6489-6494	=30ms	_
41-25	6495-6496	,	_
41-26	6497-6500	256	_
41-27	6501-6502	×	_
41-28	6503-6506	256	_
41-29	6507-6513	matrix	_
41-30	6514-6515	)	_
41-31	6516-6517	.	_

Text=Resting state fMRI datasets were collected using a single-shot gradient echo planar imaging pulse sequence with thirty-four 5mm-thick axial slices acquired parallel to the anterior/posterior commissural line (TR = 2000ms, TE = 30ms, flip angle=90o, 3.75 mm × 3.75 mm × 5.0 mm voxels).
42-1	6518-6525	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
42-2	6526-6531	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
42-3	6532-6536	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
42-4	6537-6545	datasets	_
42-5	6546-6550	were	_
42-6	6551-6560	collected	_
42-7	6561-6566	using	_
42-8	6567-6568	a	_
42-9	6569-6580	single-shot	_
42-10	6581-6589	gradient	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-11	6590-6594	echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-12	6595-6601	planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-13	6602-6609	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-14	6610-6615	pulse	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-15	6616-6624	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
42-16	6625-6629	with	_
42-17	6630-6641	thirty-four	_
42-18	6642-6651	5mm-thick	_
42-19	6652-6657	axial	_
42-20	6658-6664	slices	_
42-21	6665-6673	acquired	_
42-22	6674-6682	parallel	_
42-23	6683-6685	to	_
42-24	6686-6689	the	_
42-25	6690-6708	anterior/posterior	_
42-26	6709-6720	commissural	_
42-27	6721-6725	line	_
42-28	6726-6727	(	_
42-29	6728-6730	TR	_
42-30	6731-6732	=	_
42-31	6733-6739	2000ms	_
42-32	6740-6741	,	_
42-33	6742-6744	TE	_
42-34	6745-6746	=	_
42-35	6747-6751	30ms	_
42-36	6752-6753	,	_
42-37	6754-6758	flip	_
42-38	6759-6768	angle=90o	_
42-39	6769-6770	,	_
42-40	6771-6775	3.75	_
42-41	6776-6778	mm	_
42-42	6779-6780	×	_
42-43	6781-6785	3.75	_
42-44	6786-6788	mm	_
42-45	6789-6790	×	_
42-46	6791-6794	5.0	_
42-47	6795-6797	mm	_
42-48	6798-6804	voxels	_
42-49	6805-6806	)	_
42-50	6807-6808	.	_

Text=Therefore, for each subject a total of 150 resting state frames (volumes) were acquired.
43-1	6809-6818	Therefore	_
43-2	6819-6820	,	_
43-3	6821-6824	for	_
43-4	6825-6829	each	_
43-5	6830-6837	subject	_
43-6	6838-6839	a	_
43-7	6840-6845	total	_
43-8	6846-6848	of	_
43-9	6849-6852	150	_
43-10	6853-6860	resting	_
43-11	6861-6866	state	_
43-12	6867-6873	frames	_
43-13	6874-6875	(	_
43-14	6876-6883	volumes	_
43-15	6884-6885	)	_
43-16	6886-6890	were	_
43-17	6891-6899	acquired	_
43-18	6900-6901	.	_

Text=2.5 rs-fMRI data pre-processing Using Functional MRI of the Brain (FMRIB)'s Software Library (www.fmrib.ox.ac.uk/fsl) we applied; 1) slice timing correction for interleaved acquisitions using Sinc interpolation with a Hanning windowing kernel; 2) motion correction; 3) non-brain removal; 4) spatial smoothing using a Gaussian kernel of full width at half maximum 5mm; 5) grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor, the size of the voxels is 4×4×4 mm3; 6) high-pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma=50s); and 7) registration to high resolution structural MNI standard space images.
44-1	6902-6905	2.5	_
44-2	6906-6913	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
44-3	6914-6918	data	_
44-4	6919-6933	pre-processing	_
44-5	6934-6939	Using	_
44-6	6940-6950	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
44-7	6951-6954	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
44-8	6955-6957	of	_
44-9	6958-6961	the	_
44-10	6962-6967	Brain	_
44-11	6968-6969	(	_
44-12	6970-6975	FMRIB	_
44-13	6976-6977	)	_
44-14	6978-6980	's	_
44-15	6981-6989	Software	_
44-16	6990-6997	Library	_
44-17	6998-6999	(	_
44-18	7000-7022	www.fmrib.ox.ac.uk/fsl	_
44-19	7023-7024	)	_
44-20	7025-7027	we	_
44-21	7028-7035	applied	_
44-22	7036-7037	;	_
44-23	7038-7039	1	_
44-24	7040-7041	)	_
44-25	7042-7047	slice	_
44-26	7048-7054	timing	_
44-27	7055-7065	correction	_
44-28	7066-7069	for	_
44-29	7070-7081	interleaved	_
44-30	7082-7094	acquisitions	_
44-31	7095-7100	using	_
44-32	7101-7105	Sinc	_
44-33	7106-7119	interpolation	_
44-34	7120-7124	with	_
44-35	7125-7126	a	_
44-36	7127-7134	Hanning	_
44-37	7135-7144	windowing	_
44-38	7145-7151	kernel	_
44-39	7152-7153	;	_
44-40	7154-7155	2	_
44-41	7156-7157	)	_
44-42	7158-7164	motion	_
44-43	7165-7175	correction	_
44-44	7176-7177	;	_
44-45	7178-7179	3	_
44-46	7180-7181	)	_
44-47	7182-7191	non-brain	_
44-48	7192-7199	removal	_
44-49	7200-7201	;	_
44-50	7202-7203	4	_
44-51	7204-7205	)	_
44-52	7206-7213	spatial	_
44-53	7214-7223	smoothing	_
44-54	7224-7229	using	_
44-55	7230-7231	a	_
44-56	7232-7240	Gaussian	_
44-57	7241-7247	kernel	_
44-58	7248-7250	of	_
44-59	7251-7255	full	_
44-60	7256-7261	width	_
44-61	7262-7264	at	_
44-62	7265-7269	half	_
44-63	7270-7277	maximum	_
44-64	7278-7281	5mm	_
44-65	7282-7283	;	_
44-66	7284-7285	5	_
44-67	7286-7287	)	_
44-68	7288-7298	grand-mean	_
44-69	7299-7308	intensity	_
44-70	7309-7322	normalization	_
44-71	7323-7325	of	_
44-72	7326-7329	the	_
44-73	7330-7336	entire	_
44-74	7337-7339	4D	_
44-75	7340-7347	dataset	_
44-76	7348-7350	by	_
44-77	7351-7352	a	_
44-78	7353-7359	single	_
44-79	7360-7374	multiplicative	_
44-80	7375-7381	factor	_
44-81	7382-7383	,	_
44-82	7384-7387	the	_
44-83	7388-7392	size	_
44-84	7393-7395	of	_
44-85	7396-7399	the	_
44-86	7400-7406	voxels	_
44-87	7407-7409	is	_
44-88	7410-7415	4×4×4	_
44-89	7416-7419	mm3	_
44-90	7420-7421	;	_
44-91	7422-7423	6	_
44-92	7424-7425	)	_
44-93	7426-7435	high-pass	_
44-94	7436-7444	temporal	_
44-95	7445-7454	filtering	_
44-96	7455-7456	(	_
44-97	7457-7474	Gaussian-weighted	_
44-98	7475-7488	least-squares	_
44-99	7489-7497	straight	_
44-100	7498-7502	line	_
44-101	7503-7510	fitting	_
44-102	7511-7512	,	_
44-103	7513-7517	with	_
44-104	7518-7527	sigma=50s	_
44-105	7528-7529	)	_
44-106	7530-7531	;	_
44-107	7532-7535	and	_
44-108	7536-7537	7	_
44-109	7538-7539	)	_
44-110	7540-7552	registration	_
44-111	7553-7555	to	_
44-112	7556-7560	high	_
44-113	7561-7571	resolution	_
44-114	7572-7582	structural	_
44-115	7583-7586	MNI	_
44-116	7587-7595	standard	_
44-117	7596-7601	space	_
44-118	7602-7608	images	_
44-119	7609-7610	.	_

Text=We used a stringent threshold for head motion in pre-processing step.
45-1	7611-7613	We	_
45-2	7614-7618	used	_
45-3	7619-7620	a	_
45-4	7621-7630	stringent	_
45-5	7631-7640	threshold	_
45-6	7641-7644	for	_
45-7	7645-7649	head	_
45-8	7650-7656	motion	_
45-9	7657-7659	in	_
45-10	7660-7674	pre-processing	_
45-11	7675-7679	step	_
45-12	7680-7681	.	_

Text=Subjects with head motion greater than 0.3 mm for translation and 0.3° for rotation between consecutive TRs were removed from the study.
46-1	7682-7690	Subjects	_
46-2	7691-7695	with	_
46-3	7696-7700	head	_
46-4	7701-7707	motion	_
46-5	7708-7715	greater	_
46-6	7716-7720	than	_
46-7	7721-7724	0.3	_
46-8	7725-7727	mm	_
46-9	7728-7731	for	_
46-10	7732-7743	translation	_
46-11	7744-7747	and	_
46-12	7748-7752	0.3°	_
46-13	7753-7756	for	_
46-14	7757-7765	rotation	_
46-15	7766-7773	between	_
46-16	7774-7785	consecutive	_
46-17	7786-7789	TRs	_
46-18	7790-7794	were	_
46-19	7795-7802	removed	_
46-20	7803-7807	from	_
46-21	7808-7811	the	_
46-22	7812-7817	study	_
46-23	7818-7819	.	_

Text=2.6 rs-fMRI connectivity analysis We applied Probabilistic Independent Component Analysis (PICA) by using the Multivariate Exploratory Linear Decomposition into Independent Components (MELODIC) toolbox of the FMRIB Software library (FSL) package (www.fmrib.ox.ac.uk/fsl).
47-1	7820-7823	2.6	_
47-2	7824-7831	rs-fMRI	_
47-3	7832-7844	connectivity	_
47-4	7845-7853	analysis	_
47-5	7854-7856	We	_
47-6	7857-7864	applied	_
47-7	7865-7878	Probabilistic	_
47-8	7879-7890	Independent	_
47-9	7891-7900	Component	_
47-10	7901-7909	Analysis	_
47-11	7910-7911	(	_
47-12	7912-7916	PICA	_
47-13	7917-7918	)	_
47-14	7919-7921	by	_
47-15	7922-7927	using	_
47-16	7928-7931	the	_
47-17	7932-7944	Multivariate	_
47-18	7945-7956	Exploratory	_
47-19	7957-7963	Linear	_
47-20	7964-7977	Decomposition	_
47-21	7978-7982	into	_
47-22	7983-7994	Independent	_
47-23	7995-8005	Components	_
47-24	8006-8007	(	_
47-25	8008-8015	MELODIC	_
47-26	8016-8017	)	_
47-27	8018-8025	toolbox	_
47-28	8026-8028	of	_
47-29	8029-8032	the	_
47-30	8033-8038	FMRIB	_
47-31	8039-8047	Software	_
47-32	8048-8055	library	_
47-33	8056-8057	(	_
47-34	8058-8061	FSL	_
47-35	8062-8063	)	_
47-36	8064-8071	package	_
47-37	8072-8073	(	_
47-38	8074-8096	www.fmrib.ox.ac.uk/fsl	_
47-39	8097-8098	)	_
47-40	8099-8100	.	_

Text=A temporal concatenation tool in MELODIC was used to derive group level components across all subjects.
48-1	8101-8102	A	_
48-2	8103-8111	temporal	_
48-3	8112-8125	concatenation	_
48-4	8126-8130	tool	_
48-5	8131-8133	in	_
48-6	8134-8141	MELODIC	_
48-7	8142-8145	was	_
48-8	8146-8150	used	_
48-9	8151-8153	to	_
48-10	8154-8160	derive	_
48-11	8161-8166	group	_
48-12	8167-8172	level	_
48-13	8173-8183	components	_
48-14	8184-8190	across	_
48-15	8191-8194	all	_
48-16	8195-8203	subjects	_
48-17	8204-8205	.	_

Text=Pre-processed data were whitened and projected into a 35-dimensional subspace using PICA where the number of dimensions was estimated using the Laplace approximation to the Bayesian evidence of the model order.
49-1	8206-8219	Pre-processed	_
49-2	8220-8224	data	_
49-3	8225-8229	were	_
49-4	8230-8238	whitened	_
49-5	8239-8242	and	_
49-6	8243-8252	projected	_
49-7	8253-8257	into	_
49-8	8258-8259	a	_
49-9	8260-8274	35-dimensional	_
49-10	8275-8283	subspace	_
49-11	8284-8289	using	_
49-12	8290-8294	PICA	_
49-13	8295-8300	where	_
49-14	8301-8304	the	_
49-15	8305-8311	number	_
49-16	8312-8314	of	_
49-17	8315-8325	dimensions	_
49-18	8326-8329	was	_
49-19	8330-8339	estimated	_
49-20	8340-8345	using	_
49-21	8346-8349	the	_
49-22	8350-8357	Laplace	_
49-23	8358-8371	approximation	_
49-24	8372-8374	to	_
49-25	8375-8378	the	_
49-26	8379-8387	Bayesian	_
49-27	8388-8396	evidence	_
49-28	8397-8399	of	_
49-29	8400-8403	the	_
49-30	8404-8409	model	_
49-31	8410-8415	order	_
49-32	8416-8417	.	_

Text=The whitened observations were decomposed into sets of vectors that describe signal variation across the temporal domain (time-courses) and across the spatial domain (maps) by optimizing for non-Gaussian spatial source distributions using a fixed-point iteration technique.
50-1	8418-8421	The	_
50-2	8422-8430	whitened	_
50-3	8431-8443	observations	_
50-4	8444-8448	were	_
50-5	8449-8459	decomposed	_
50-6	8460-8464	into	_
50-7	8465-8469	sets	_
50-8	8470-8472	of	_
50-9	8473-8480	vectors	_
50-10	8481-8485	that	_
50-11	8486-8494	describe	_
50-12	8495-8501	signal	_
50-13	8502-8511	variation	_
50-14	8512-8518	across	_
50-15	8519-8522	the	_
50-16	8523-8531	temporal	_
50-17	8532-8538	domain	_
50-18	8539-8540	(	_
50-19	8541-8553	time-courses	_
50-20	8554-8555	)	_
50-21	8556-8559	and	_
50-22	8560-8566	across	_
50-23	8567-8570	the	_
50-24	8571-8578	spatial	_
50-25	8579-8585	domain	_
50-26	8586-8587	(	_
50-27	8588-8592	maps	_
50-28	8593-8594	)	_
50-29	8595-8597	by	_
50-30	8598-8608	optimizing	_
50-31	8609-8612	for	_
50-32	8613-8625	non-Gaussian	_
50-33	8626-8633	spatial	_
50-34	8634-8640	source	_
50-35	8641-8654	distributions	_
50-36	8655-8660	using	_
50-37	8661-8662	a	_
50-38	8663-8674	fixed-point	_
50-39	8675-8684	iteration	_
50-40	8685-8694	technique	_
50-41	8695-8696	.	_

Text=These FC components maps were standardized into z statistic images via a normalized mixture model fit, thresholded at z> 5.
51-1	8697-8702	These	_
51-2	8703-8705	FC	_
51-3	8706-8716	components	_
51-4	8717-8721	maps	_
51-5	8722-8726	were	_
51-6	8727-8739	standardized	_
51-7	8740-8744	into	_
51-8	8745-8746	z	_
51-9	8747-8756	statistic	_
51-10	8757-8763	images	_
51-11	8764-8767	via	_
51-12	8768-8769	a	_
51-13	8770-8780	normalized	_
51-14	8781-8788	mixture	_
51-15	8789-8794	model	_
51-16	8795-8798	fit	_
51-17	8799-8800	,	_
51-18	8801-8812	thresholded	_
51-19	8813-8815	at	_
51-20	8816-8817	z	_
51-21	8818-8819	>	_
51-22	8820-8821	5	_
51-23	8822-8823	.	_

Text=Two criteria were used to remove biologically irrelevant components: (1) those representing known artifacts such as motion, and high-frequency noise; and (2) those with connectivity patterns not located mainly in gray matter.
52-1	8824-8827	Two	_
52-2	8828-8836	criteria	_
52-3	8837-8841	were	_
52-4	8842-8846	used	_
52-5	8847-8849	to	_
52-6	8850-8856	remove	_
52-7	8857-8869	biologically	_
52-8	8870-8880	irrelevant	_
52-9	8881-8891	components	_
52-10	8892-8893	:	_
52-11	8894-8895	(	_
52-12	8896-8897	1	_
52-13	8898-8899	)	_
52-14	8900-8905	those	_
52-15	8906-8918	representing	_
52-16	8919-8924	known	_
52-17	8925-8934	artifacts	_
52-18	8935-8939	such	_
52-19	8940-8942	as	_
52-20	8943-8949	motion	_
52-21	8950-8951	,	_
52-22	8952-8955	and	_
52-23	8956-8970	high-frequency	_
52-24	8971-8976	noise	_
52-25	8977-8978	;	_
52-26	8979-8982	and	_
52-27	8983-8984	(	_
52-28	8985-8986	2	_
52-29	8987-8988	)	_
52-30	8989-8994	those	_
52-31	8995-8999	with	_
52-32	9000-9012	connectivity	_
52-33	9013-9021	patterns	_
52-34	9022-9025	not	_
52-35	9026-9033	located	_
52-36	9034-9040	mainly	_
52-37	9041-9043	in	_
52-38	9044-9048	gray	_
52-39	9049-9055	matter	_
52-40	9056-9057	.	_

Text=Networks of interest were identified as anatomically and functionally classical RSNs upon visual inspection.
53-1	9058-9066	Networks	_
53-2	9067-9069	of	_
53-3	9070-9078	interest	_
53-4	9079-9083	were	_
53-5	9084-9094	identified	_
53-6	9095-9097	as	_
53-7	9098-9110	anatomically	_
53-8	9111-9114	and	_
53-9	9115-9127	functionally	_
53-10	9128-9137	classical	_
53-11	9138-9142	RSNs	_
53-12	9143-9147	upon	_
53-13	9148-9154	visual	_
53-14	9155-9165	inspection	_
53-15	9166-9167	.	_

Text=The between-subject analysis was carried out using dual regression, a regression technique that back-reconstructs each group level component map at the individual subject level.
54-1	9168-9171	The	_
54-2	9172-9187	between-subject	_
54-3	9188-9196	analysis	_
54-4	9197-9200	was	_
54-5	9201-9208	carried	_
54-6	9209-9212	out	_
54-7	9213-9218	using	_
54-8	9219-9223	dual	_
54-9	9224-9234	regression	_
54-10	9235-9236	,	_
54-11	9237-9238	a	_
54-12	9239-9249	regression	_
54-13	9250-9259	technique	_
54-14	9260-9264	that	_
54-15	9265-9282	back-reconstructs	_
54-16	9283-9287	each	_
54-17	9288-9293	group	_
54-18	9294-9299	level	_
54-19	9300-9309	component	_
54-20	9310-9313	map	_
54-21	9314-9316	at	_
54-22	9317-9320	the	_
54-23	9321-9331	individual	_
54-24	9332-9339	subject	_
54-25	9340-9345	level	_
54-26	9346-9347	.	_

Text=This technique allows for voxel-wise comparisons of resting state FC by carrying out the following steps: First, regresses the group level spatial maps into each individual ’ s 4D dataset to obtain a set of time series.
55-1	9348-9352	This	_
55-2	9353-9362	technique	_
55-3	9363-9369	allows	_
55-4	9370-9373	for	_
55-5	9374-9384	voxel-wise	_
55-6	9385-9396	comparisons	_
55-7	9397-9399	of	_
55-8	9400-9407	resting	_
55-9	9408-9413	state	_
55-10	9414-9416	FC	_
55-11	9417-9419	by	_
55-12	9420-9428	carrying	_
55-13	9429-9432	out	_
55-14	9433-9436	the	_
55-15	9437-9446	following	_
55-16	9447-9452	steps	_
55-17	9453-9454	:	_
55-18	9455-9460	First	_
55-19	9461-9462	,	_
55-20	9463-9472	regresses	_
55-21	9473-9476	the	_
55-22	9477-9482	group	_
55-23	9483-9488	level	_
55-24	9489-9496	spatial	_
55-25	9497-9501	maps	_
55-26	9502-9506	into	_
55-27	9507-9511	each	_
55-28	9512-9522	individual	_
55-29	9523-9524	’	_
55-30	9525-9526	s	_
55-31	9527-9529	4D	_
55-32	9530-9537	dataset	_
55-33	9538-9540	to	_
55-34	9541-9547	obtain	_
55-35	9548-9549	a	_
55-36	9550-9553	set	_
55-37	9554-9556	of	_
55-38	9557-9561	time	_
55-39	9562-9568	series	_
55-40	9569-9570	.	_

Text=Then, regresses those individual level time series into the same 4D dataset to obtain a subject-specific set of spatial maps.
56-1	9571-9575	Then	_
56-2	9576-9577	,	_
56-3	9578-9587	regresses	_
56-4	9588-9593	those	_
56-5	9594-9604	individual	_
56-6	9605-9610	level	_
56-7	9611-9615	time	_
56-8	9616-9622	series	_
56-9	9623-9627	into	_
56-10	9628-9631	the	_
56-11	9632-9636	same	_
56-12	9637-9639	4D	_
56-13	9640-9647	dataset	_
56-14	9648-9650	to	_
56-15	9651-9657	obtain	_
56-16	9658-9659	a	_
56-17	9660-9676	subject-specific	_
56-18	9677-9680	set	_
56-19	9681-9683	of	_
56-20	9684-9691	spatial	_
56-21	9692-9696	maps	_
56-22	9697-9698	.	_

Text=Statistic inferences were then tested using FSL ’ s randomize permutation-testing tool.
57-1	9699-9708	Statistic	_
57-2	9709-9719	inferences	_
57-3	9720-9724	were	_
57-4	9725-9729	then	_
57-5	9730-9736	tested	_
57-6	9737-9742	using	_
57-7	9743-9746	FSL	_
57-8	9747-9748	’	_
57-9	9749-9750	s	_
57-10	9751-9760	randomize	_
57-11	9761-9780	permutation-testing	_
57-12	9781-9785	tool	_
57-13	9786-9787	.	_

Text=In cases such as fMRI data, when the null distribution is not known, permutation testing is used for inference on statistical maps.
58-1	9788-9790	In	_
58-2	9791-9796	cases	_
58-3	9797-9801	such	_
58-4	9802-9804	as	_
58-5	9805-9809	fMRI	_
58-6	9810-9814	data	_
58-7	9815-9816	,	_
58-8	9817-9821	when	_
58-9	9822-9825	the	_
58-10	9826-9830	null	_
58-11	9831-9843	distribution	_
58-12	9844-9846	is	_
58-13	9847-9850	not	_
58-14	9851-9856	known	_
58-15	9857-9858	,	_
58-16	9859-9870	permutation	_
58-17	9871-9878	testing	_
58-18	9879-9881	is	_
58-19	9882-9886	used	_
58-20	9887-9890	for	_
58-21	9891-9900	inference	_
58-22	9901-9903	on	_
58-23	9904-9915	statistical	_
58-24	9916-9920	maps	_
58-25	9921-9922	.	_

Text=Voxel-wise two-sample t-test was carried out to assess statistically significant differences in FC between the groups using a 5000 non-parametric permutation testing.
59-1	9923-9933	Voxel-wise	_
59-2	9934-9944	two-sample	_
59-3	9945-9951	t-test	_
59-4	9952-9955	was	_
59-5	9956-9963	carried	_
59-6	9964-9967	out	_
59-7	9968-9970	to	_
59-8	9971-9977	assess	_
59-9	9978-9991	statistically	_
59-10	9992-10003	significant	_
59-11	10004-10015	differences	_
59-12	10016-10018	in	_
59-13	10019-10021	FC	_
59-14	10022-10029	between	_
59-15	10030-10033	the	_
59-16	10034-10040	groups	_
59-17	10041-10046	using	_
59-18	10047-10048	a	_
59-19	10049-10053	5000	_
59-20	10054-10068	non-parametric	_
59-21	10069-10080	permutation	_
59-22	10081-10088	testing	_
59-23	10089-10090	.	_

Text=We utilized a threshold-free cluster enhanced (TFCE) technique to control for multiple comparisons.
60-1	10091-10093	We	_
60-2	10094-10102	utilized	_
60-3	10103-10104	a	_
60-4	10105-10119	threshold-free	_
60-5	10120-10127	cluster	_
60-6	10128-10136	enhanced	_
60-7	10137-10138	(	_
60-8	10139-10143	TFCE	_
60-9	10144-10145	)	_
60-10	10146-10155	technique	_
60-11	10156-10158	to	_
60-12	10159-10166	control	_
60-13	10167-10170	for	_
60-14	10171-10179	multiple	_
60-15	10180-10191	comparisons	_
60-16	10192-10193	.	_

Text=This method allows detecting significant clusters without having to define cluster size or the number of clusters prior to analysis.
61-1	10194-10198	This	_
61-2	10199-10205	method	_
61-3	10206-10212	allows	_
61-4	10213-10222	detecting	_
61-5	10223-10234	significant	_
61-6	10235-10243	clusters	_
61-7	10244-10251	without	_
61-8	10252-10258	having	_
61-9	10259-10261	to	_
61-10	10262-10268	define	_
61-11	10269-10276	cluster	_
61-12	10277-10281	size	_
61-13	10282-10284	or	_
61-14	10285-10288	the	_
61-15	10289-10295	number	_
61-16	10296-10298	of	_
61-17	10299-10307	clusters	_
61-18	10308-10313	prior	_
61-19	10314-10316	to	_
61-20	10317-10325	analysis	_
61-21	10326-10327	.	_

Text=Finally, the resulting statistical maps were threshold at p <0.05 FWE-corrected for multiple comparisons for the main group effect.
62-1	10328-10335	Finally	_
62-2	10336-10337	,	_
62-3	10338-10341	the	_
62-4	10342-10351	resulting	_
62-5	10352-10363	statistical	_
62-6	10364-10368	maps	_
62-7	10369-10373	were	_
62-8	10374-10383	threshold	_
62-9	10384-10386	at	_
62-10	10387-10388	p	_
62-11	10389-10390	<	_
62-12	10391-10395	0.05	_
62-13	10396-10409	FWE-corrected	_
62-14	10410-10413	for	_
62-15	10414-10422	multiple	_
62-16	10423-10434	comparisons	_
62-17	10435-10438	for	_
62-18	10439-10442	the	_
62-19	10443-10447	main	_
62-20	10448-10453	group	_
62-21	10454-10460	effect	_
62-22	10461-10462	.	_

Text=This step generated the probabilistic maps which represent the probability of FC between AD and HC: AD maps subtracted from HC one and vice versa for all RSNs of interest.
63-1	10463-10467	This	_
63-2	10468-10472	step	_
63-3	10473-10482	generated	_
63-4	10483-10486	the	_
63-5	10487-10500	probabilistic	_
63-6	10501-10505	maps	_
63-7	10506-10511	which	_
63-8	10512-10521	represent	_
63-9	10522-10525	the	_
63-10	10526-10537	probability	_
63-11	10538-10540	of	_
63-12	10541-10543	FC	_
63-13	10544-10551	between	_
63-14	10552-10554	AD	_
63-15	10555-10558	and	_
63-16	10559-10561	HC	_
63-17	10562-10563	:	_
63-18	10564-10566	AD	_
63-19	10567-10571	maps	_
63-20	10572-10582	subtracted	_
63-21	10583-10587	from	_
63-22	10588-10590	HC	_
63-23	10591-10594	one	_
63-24	10595-10598	and	_
63-25	10599-10603	vice	_
63-26	10604-10609	versa	_
63-27	10610-10613	for	_
63-28	10614-10617	all	_
63-29	10618-10622	RSNs	_
63-30	10623-10625	of	_
63-31	10626-10634	interest	_
63-32	10635-10636	.	_

Text=The Harvard-Oxford cortical and subcortical atlases incorporated in FSL were used to identify the anatomical regions of the resulting PICA maps.
64-1	10637-10640	The	_
64-2	10641-10655	Harvard-Oxford	_
64-3	10656-10664	cortical	_
64-4	10665-10668	and	_
64-5	10669-10680	subcortical	_
64-6	10681-10688	atlases	_
64-7	10689-10701	incorporated	_
64-8	10702-10704	in	_
64-9	10705-10708	FSL	_
64-10	10709-10713	were	_
64-11	10714-10718	used	_
64-12	10719-10721	to	_
64-13	10722-10730	identify	_
64-14	10731-10734	the	_
64-15	10735-10745	anatomical	_
64-16	10746-10753	regions	_
64-17	10754-10756	of	_
64-18	10757-10760	the	_
64-19	10761-10770	resulting	_
64-20	10771-10775	PICA	_
64-21	10776-10780	maps	_
64-22	10781-10782	.	_

Text=2.7 Correlation Analysis Within-network connectivity correlation with impulsivity measures: Using Statistical Parametric Mapping 8 (SPM8) (http: //www.fil.ion.ucl.ac.uk/spm), for each group, individual subject maps for the independent components for the impulsive system (ASN), reflective system (OFCN, left ECN, right ECN), insula cortex (SN) and DMN (a-DMN and p-DMN), were entered as second-level regression analysis versus the impulsivity measures (BIS-11, DDT, UPPS-P) as covariate with its own IC map as mask.
65-1	10783-10786	2.7	_
65-2	10787-10798	Correlation	_
65-3	10799-10807	Analysis	_
65-4	10808-10822	Within-network	_
65-5	10823-10835	connectivity	_
65-6	10836-10847	correlation	_
65-7	10848-10852	with	_
65-8	10853-10864	impulsivity	_
65-9	10865-10873	measures	_
65-10	10874-10875	:	_
65-11	10876-10881	Using	_
65-12	10882-10893	Statistical	_
65-13	10894-10904	Parametric	_
65-14	10905-10912	Mapping	_
65-15	10913-10914	8	_
65-16	10915-10916	(	_
65-17	10917-10921	SPM8	_
65-18	10922-10923	)	_
65-19	10924-10925	(	_
65-20	10926-10930	http	_
65-21	10931-10932	:	_
65-22	10933-10960	//www.fil.ion.ucl.ac.uk/spm	_
65-23	10961-10962	)	_
65-24	10963-10964	,	_
65-25	10965-10968	for	_
65-26	10969-10973	each	_
65-27	10974-10979	group	_
65-28	10980-10981	,	_
65-29	10982-10992	individual	_
65-30	10993-11000	subject	_
65-31	11001-11005	maps	_
65-32	11006-11009	for	_
65-33	11010-11013	the	_
65-34	11014-11025	independent	_
65-35	11026-11036	components	_
65-36	11037-11040	for	_
65-37	11041-11044	the	_
65-38	11045-11054	impulsive	_
65-39	11055-11061	system	_
65-40	11062-11063	(	_
65-41	11064-11067	ASN	_
65-42	11068-11069	)	_
65-43	11070-11071	,	_
65-44	11072-11082	reflective	_
65-45	11083-11089	system	_
65-46	11090-11091	(	_
65-47	11092-11096	OFCN	_
65-48	11097-11098	,	_
65-49	11099-11103	left	_
65-50	11104-11107	ECN	_
65-51	11108-11109	,	_
65-52	11110-11115	right	_
65-53	11116-11119	ECN	_
65-54	11120-11121	)	_
65-55	11122-11123	,	_
65-56	11124-11130	insula	_
65-57	11131-11137	cortex	_
65-58	11138-11139	(	_
65-59	11140-11142	SN	_
65-60	11143-11144	)	_
65-61	11145-11148	and	_
65-62	11149-11152	DMN	_
65-63	11153-11154	(	_
65-64	11155-11160	a-DMN	_
65-65	11161-11164	and	_
65-66	11165-11170	p-DMN	_
65-67	11171-11172	)	_
65-68	11173-11174	,	_
65-69	11175-11179	were	_
65-70	11180-11187	entered	_
65-71	11188-11190	as	_
65-72	11191-11203	second-level	_
65-73	11204-11214	regression	_
65-74	11215-11223	analysis	_
65-75	11224-11230	versus	_
65-76	11231-11234	the	_
65-77	11235-11246	impulsivity	_
65-78	11247-11255	measures	_
65-79	11256-11257	(	_
65-80	11258-11264	BIS-11	_
65-81	11265-11266	,	_
65-82	11267-11270	DDT	_
65-83	11271-11272	,	_
65-84	11273-11279	UPPS-P	_
65-85	11280-11281	)	_
65-86	11282-11284	as	_
65-87	11285-11294	covariate	_
65-88	11295-11299	with	_
65-89	11300-11303	its	_
65-90	11304-11307	own	_
65-91	11308-11310	IC	_
65-92	11311-11314	map	_
65-93	11315-11317	as	_
65-94	11318-11322	mask	_
65-95	11323-11324	.	_

Text=All within-RSN correlational analyses were done with the cluster-level Family-wise error (FWE) corrected threshold of 0.05.
66-1	11325-11328	All	_
66-2	11329-11339	within-RSN	_
66-3	11340-11353	correlational	_
66-4	11354-11362	analyses	_
66-5	11363-11367	were	_
66-6	11368-11372	done	_
66-7	11373-11377	with	_
66-8	11378-11381	the	_
66-9	11382-11395	cluster-level	_
66-10	11396-11407	Family-wise	_
66-11	11408-11413	error	_
66-12	11414-11415	(	_
66-13	11416-11419	FWE	_
66-14	11420-11421	)	_
66-15	11422-11431	corrected	_
66-16	11432-11441	threshold	_
66-17	11442-11444	of	_
66-18	11445-11449	0.05	_
66-19	11450-11451	.	_

Text=Between-network connectivity correlation with clinical measures: Even though all component maps are spatially independent, time series of the components may still have significant temporal correlations.
67-1	11452-11467	Between-network	_
67-2	11468-11480	connectivity	_
67-3	11481-11492	correlation	_
67-4	11493-11497	with	_
67-5	11498-11506	clinical	_
67-6	11507-11515	measures	_
67-7	11516-11517	:	_
67-8	11518-11522	Even	_
67-9	11523-11529	though	_
67-10	11530-11533	all	_
67-11	11534-11543	component	_
67-12	11544-11548	maps	_
67-13	11549-11552	are	_
67-14	11553-11562	spatially	_
67-15	11563-11574	independent	_
67-16	11575-11576	,	_
67-17	11577-11581	time	_
67-18	11582-11588	series	_
67-19	11589-11591	of	_
67-20	11592-11595	the	_
67-21	11596-11606	components	_
67-22	11607-11610	may	_
67-23	11611-11616	still	_
67-24	11617-11621	have	_
67-25	11622-11633	significant	_
67-26	11634-11642	temporal	_
67-27	11643-11655	correlations	_
67-28	11656-11657	.	_

Text=Network interaction comparisons (Correlation coefficients, Pearson ’ s r) between AD and HC were computed between each subject time series for the RSNs of interest that were obtained by the first stage of the dual regression procedure.
68-1	11658-11665	Network	_
68-2	11666-11677	interaction	_
68-3	11678-11689	comparisons	_
68-4	11690-11691	(	_
68-5	11692-11703	Correlation	_
68-6	11704-11716	coefficients	_
68-7	11717-11718	,	_
68-8	11719-11726	Pearson	_
68-9	11727-11728	’	_
68-10	11729-11730	s	_
68-11	11731-11732	r	_
68-12	11733-11734	)	_
68-13	11735-11742	between	_
68-14	11743-11745	AD	_
68-15	11746-11749	and	_
68-16	11750-11752	HC	_
68-17	11753-11757	were	_
68-18	11758-11766	computed	_
68-19	11767-11774	between	_
68-20	11775-11779	each	_
68-21	11780-11787	subject	_
68-22	11788-11792	time	_
68-23	11793-11799	series	_
68-24	11800-11803	for	_
68-25	11804-11807	the	_
68-26	11808-11812	RSNs	_
68-27	11813-11815	of	_
68-28	11816-11824	interest	_
68-29	11825-11829	that	_
68-30	11830-11834	were	_
68-31	11835-11843	obtained	_
68-32	11844-11846	by	_
68-33	11847-11850	the	_
68-34	11851-11856	first	_
68-35	11857-11862	stage	_
68-36	11863-11865	of	_
68-37	11866-11869	the	_
68-38	11870-11874	dual	_
68-39	11875-11885	regression	_
68-40	11886-11895	procedure	_
68-41	11896-11897	.	_

Text=These correlation coefficients were Fisher z-transformed and unpaired t-tests were conducted to compare between network connectivity in AD and HC using Statistical Analysis System (SAS software, Copyright, SAS Institute Inc. SAS and all other SAS Institute Inc.).
69-1	11898-11903	These	_
69-2	11904-11915	correlation	_
69-3	11916-11928	coefficients	_
69-4	11929-11933	were	_
69-5	11934-11940	Fisher	_
69-6	11941-11954	z-transformed	_
69-7	11955-11958	and	_
69-8	11959-11967	unpaired	_
69-9	11968-11975	t-tests	_
69-10	11976-11980	were	_
69-11	11981-11990	conducted	_
69-12	11991-11993	to	_
69-13	11994-12001	compare	_
69-14	12002-12009	between	_
69-15	12010-12017	network	_
69-16	12018-12030	connectivity	_
69-17	12031-12033	in	_
69-18	12034-12036	AD	_
69-19	12037-12040	and	_
69-20	12041-12043	HC	_
69-21	12044-12049	using	_
69-22	12050-12061	Statistical	_
69-23	12062-12070	Analysis	_
69-24	12071-12077	System	_
69-25	12078-12079	(	_
69-26	12080-12083	SAS	_
69-27	12084-12092	software	_
69-28	12093-12094	,	_
69-29	12095-12104	Copyright	_
69-30	12105-12106	,	_
69-31	12107-12110	SAS	_
69-32	12111-12120	Institute	_
69-33	12121-12125	Inc.	_
69-34	12126-12129	SAS	_
69-35	12130-12133	and	_
69-36	12134-12137	all	_
69-37	12138-12143	other	_
69-38	12144-12147	SAS	_
69-39	12148-12157	Institute	_
69-40	12158-12162	Inc.	_
69-41	12163-12164	)	_
69-42	12165-12166	.	_

Text=Finally, the results were threshold at p <0.05 bonferroni-corrected for multiple comparisons.
70-1	12167-12174	Finally	_
70-2	12175-12176	,	_
70-3	12177-12180	the	_
70-4	12181-12188	results	_
70-5	12189-12193	were	_
70-6	12194-12203	threshold	_
70-7	12204-12206	at	_
70-8	12207-12208	p	_
70-9	12209-12210	<	_
70-10	12211-12215	0.05	_
70-11	12216-12236	bonferroni-corrected	_
70-12	12237-12240	for	_
70-13	12241-12249	multiple	_
70-14	12250-12261	comparisons	_
70-15	12262-12263	.	_

Text=The differences in age, years of education, and IQ between AD and HC do not make for ideal comparisons.
71-1	12264-12267	The	_
71-2	12268-12279	differences	_
71-3	12280-12282	in	_
71-4	12283-12286	age	_
71-5	12287-12288	,	_
71-6	12289-12294	years	_
71-7	12295-12297	of	_
71-8	12298-12307	education	_
71-9	12308-12309	,	_
71-10	12310-12313	and	_
71-11	12314-12316	IQ	_
71-12	12317-12324	between	_
71-13	12325-12327	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
71-14	12328-12331	and	_
71-15	12332-12334	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
71-16	12335-12337	do	_
71-17	12338-12341	not	_
71-18	12342-12346	make	_
71-19	12347-12350	for	_
71-20	12351-12356	ideal	_
71-21	12357-12368	comparisons	_
71-22	12369-12370	.	_

Text=To minimize the potential confounding influence of age, years of education and IQ in these results, these parameters were used as nuisance covariates for each network of interest.
72-1	12371-12373	To	_
72-2	12374-12382	minimize	_
72-3	12383-12386	the	_
72-4	12387-12396	potential	_
72-5	12397-12408	confounding	_
72-6	12409-12418	influence	_
72-7	12419-12421	of	_
72-8	12422-12425	age	_
72-9	12426-12427	,	_
72-10	12428-12433	years	_
72-11	12434-12436	of	_
72-12	12437-12446	education	_
72-13	12447-12450	and	_
72-14	12451-12453	IQ	_
72-15	12454-12456	in	_
72-16	12457-12462	these	_
72-17	12463-12470	results	_
72-18	12471-12472	,	_
72-19	12473-12478	these	_
72-20	12479-12489	parameters	_
72-21	12490-12494	were	_
72-22	12495-12499	used	_
72-23	12500-12502	as	_
72-24	12503-12511	nuisance	_
72-25	12512-12522	covariates	_
72-26	12523-12526	for	_
72-27	12527-12531	each	_
72-28	12532-12539	network	_
72-29	12540-12542	of	_
72-30	12543-12551	interest	_
72-31	12552-12553	.	_

Text=No effect of age, years of education and IQ was detected in the fMRI FC results.
73-1	12554-12556	No	_
73-2	12557-12563	effect	_
73-3	12564-12566	of	_
73-4	12567-12570	age	_
73-5	12571-12572	,	_
73-6	12573-12578	years	_
73-7	12579-12581	of	_
73-8	12582-12591	education	_
73-9	12592-12595	and	_
73-10	12596-12598	IQ	_
73-11	12599-12602	was	_
73-12	12603-12611	detected	_
73-13	12612-12614	in	_
73-14	12615-12618	the	_
73-15	12619-12623	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
73-16	12624-12626	FC	_
73-17	12627-12634	results	_
73-18	12635-12636	.	_

